| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/09/2013 | CN102864151A Novel synthetic agonists of tlr9 |
| 01/09/2013 | CN102863901A Method for extracting coreopsis tinctoria oil resin by using supercritical or subcritical CO2 |
| 01/09/2013 | CN102863532A Interferon alpha receptor 1 antibodies and their uses |
| 01/09/2013 | CN102863531A CD20-resistant monoclonal antibody as well as preparation method and application thereof |
| 01/09/2013 | CN102863432A Modulators of cftr |
| 01/09/2013 | CN102863345A Amino propylene glycol derivative, preparation method of amino propylene glycol derivative, medicine composition of amino propylene glycol derivative and application of amino propylene glycol derivative |
| 01/09/2013 | CN102861340A Intelligent nano delivery system, preparation method and application thereof |
| 01/09/2013 | CN102861319A Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 01/09/2013 | CN102861260A Traditional Chinese medicine for increasing immunity |
| 01/09/2013 | CN102861235A Health-maintaining preparation made of pure traditional Chinese medicines |
| 01/09/2013 | CN102861221A Drug for recuperating immunity of organisms after fire burn and preparation method thereof |
| 01/09/2013 | CN102861182A Decoction medicine for treating chronic urticaria |
| 01/09/2013 | CN102861165A Traditional Chinese medicine preparation for treating lupus erythematosus |
| 01/09/2013 | CN102861122A Preparation process of radix astragali and slender acanthopanax particles for veterinary use |
| 01/09/2013 | CN102860999A 1-deoxidation-D-xylulose5-phosphoric acid reduction isomerization enzyme inhibitor and preparation method thereof |
| 01/09/2013 | CN102860996A Method for preparing lycoypene microcapsule |
| 01/09/2013 | CN102860986A Stable taste-masking levocetirizine medicine composition and preparation method thereof |
| 01/09/2013 | CN102860971A Compound toothpaste with functions of antisepsis, anti-inflammation, acid prevention and desensitization, and preparation method thereof |
| 01/09/2013 | CN102860965A Antianaphylaxis toothpaste |
| 01/09/2013 | CN102860518A Smashing-free fruit active ingredient extracting method |
| 01/09/2013 | CN102860429A Concentrated feed for small tailed han sheep and method for preparing same |
| 01/09/2013 | CN102188135B Chinese medicine pillow for preventing and treating cold |
| 01/09/2013 | CN102161998B Deoxyribonucleic acid (DNA) vaccine based on B7-1-PE40KDEL exotoxin fusion gene and application thereof |
| 01/09/2013 | CN102138945B Method of extracting active substances with high content of flavones from ginkgo leaves |
| 01/09/2013 | CN102040643B Ciclesonide nitrate derivative |
| 01/09/2013 | CN101896482B Novel thiophene derivatives as S1P1/EDG1 agonist |
| 01/09/2013 | CN101522645B Phenyl derivatives and their use as immunomodulators |
| 01/09/2013 | CN101268095B Bifunctional protein anchors |
| 01/09/2013 | CN101227894B Rapidly disintegratable oral tablet |
| 01/09/2013 | CN101124318B Novel strain conferring anti-disease properties to host and bacterial cell composition |
| 01/09/2013 | CN101068540B Antiviral and immunostimulating marine fish oil composition |
| 01/08/2013 | US8349896 Aspirin-triggered lipid mediators |
| 01/08/2013 | US8349848 Pyrrolo[3,2-D]pyrimidines that are selective antagonists of A2B adenosine receptors |
| 01/08/2013 | US8349331 Anti-interferon-α antibodies |
| 01/08/2013 | CA2653941C Substituted amino purine derivatives and uses thereof |
| 01/08/2013 | CA2514667C Adjuvanted influenza vaccine |
| 01/08/2013 | CA2507710C Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators |
| 01/08/2013 | CA2490121C Modified phospholipids |
| 01/08/2013 | CA2489004C Agonistic binding molecules to the human ox40 receptor |
| 01/08/2013 | CA2478065C Macrocyclic compounds useful as pharmaceuticals |
| 01/08/2013 | CA2441577C Therapeutic agents for inflammatory bowel diseases |
| 01/08/2013 | CA2390095C Method and system to remove cytokine inhibitor in patients |
| 01/08/2013 | CA2388337C Method of inducing and/or enhancing an immune response to tumor antigens |
| 01/08/2013 | CA2341352C Oral vaccine compositions |
| 01/08/2013 | CA2223608C Vaccine for porcine reproductive and respiratory syndrome virus |
| 01/03/2013 | WO2013003825A1 Alcaftadine for use in the treatment of urticaria |
| 01/03/2013 | WO2013003641A2 Serpin fusion polypeptides and methods of use thereof |
| 01/03/2013 | WO2013003557A1 Photoactivatable receptors and their uses |
| 01/03/2013 | WO2013003112A1 Methods and compositions for treatment of cancer and autoimmune disease |
| 01/03/2013 | WO2013002364A1 Crystals of glycine derivative and pharmaceutical use thereof |
| 01/03/2013 | WO2013002248A1 Phosphoric acid ester derivative |
| 01/03/2013 | WO2013002196A1 Novel pharmaceutical composition |
| 01/03/2013 | WO2013001890A1 Soyasapogenol composition |
| 01/03/2013 | WO2013001819A1 SOLUBLE INTEGRIN α4 MUTANT |
| 01/03/2013 | WO2013001517A1 Polypeptides and uses thereof for treatment of autoimmune disorders and infection |
| 01/03/2013 | WO2013001310A1 Macrocyclic compounds and their use as cdk8 inhibitors |
| 01/03/2013 | WO2013001294A1 Crystalline form of indazolyl amide derivatives for the treatment glucocorticoid receptor mediated disorders |
| 01/03/2013 | WO2013000974A1 Methods for treating immune-mediated diseases of the nervous system administering a compound comprising agents that inhibit prokineticin receptors activity |
| 01/03/2013 | WO2013000406A1 Benzocycloheptanethiophene derivatives for anti-allergic reactions |
| 01/03/2013 | WO2013000395A1 Novel histone deacetylase inhibitor of benzamides and use thereof |
| 01/03/2013 | WO2013000234A1 A novel recomnimant bifunctional fusion protein and its preparation and use |
| 01/03/2013 | WO2012118863A9 Therapies that target autoimmunity for treating glaucoma and optic neuropathy |
| 01/03/2013 | WO2009095796A3 Tapasin augmentation for enhanced immune response |
| 01/03/2013 | US20130005812 Method for alleviating allergic asthma and allergic response by using bitter melon composition |
| 01/03/2013 | US20130005782 Method for integrin ligand discovery |
| 01/03/2013 | US20130005781 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents |
| 01/03/2013 | US20130005766 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 01/03/2013 | US20130005762 Combination of droloxifene and clopidogrel |
| 01/03/2013 | US20130005758 Manufacture, method and use of drug-eluting medical devices for permanently keeping blood vessels open |
| 01/03/2013 | US20130005749 Novel formulation and treatment methods |
| 01/03/2013 | US20130005748 Compounds and compositions as protein kinase inhibitors |
| 01/03/2013 | US20130005745 Inhibitors of bruton's tyrosine kinase |
| 01/03/2013 | US20130005741 Substituted pyrimidine as a prostaglandin d2 receptor antagonist |
| 01/03/2013 | US20130005740 Process for preparation of over-the-counter gelatin or pectin-based drug delivery |
| 01/03/2013 | US20130005735 Organic compounds |
| 01/03/2013 | US20130005728 Substituted pyrimidines as prostaglandin d2 receptor antagonists |
| 01/03/2013 | US20130005726 Compositions and methods for treating inflammatory disorders |
| 01/03/2013 | US20130005724 Pyridino-pyridinone derivatives, preparation and therapeutic use thereof |
| 01/03/2013 | US20130005707 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith |
| 01/03/2013 | US20130005694 Liquid compositions comprising vitamin d and uses thereof |
| 01/03/2013 | US20130005686 2-Methylene-(22E)-25-Hexanoyl-24-OXO-26,27-Cyclo-22-Dehydro-19-Nor-Vitamin D Analogs |
| 01/03/2013 | US20130005659 Il-17 binding compounds and medical uses thereof |
| 01/03/2013 | US20130005644 Cyclic agonists and antagonists of c5a receptors and g protein-coupled receptors |
| 01/03/2013 | US20130004977 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 01/03/2013 | US20130004579 Use of Plant Lectins to Target Leukocytes |
| 01/03/2013 | US20130004547 Oral vaccines produced and administered using edible micro-organisms including lactic acid bacterial strains |
| 01/03/2013 | US20130004542 Composition |
| 01/03/2013 | US20130004540 Bifidobacterium strain |
| 01/03/2013 | US20130004538 Methods and compositions for modulating an immune response with immunogenic oligonucleotides |
| 01/03/2013 | US20130004537 BACTERIUM COMPRISING A REGULATED rfaH NUCLEIC ACID |
| 01/03/2013 | US20130004536 Multiple vaccination including serogroup c meningococcus |
| 01/03/2013 | US20130004535 Multiple vaccination including serogroup c meningococcus |
| 01/03/2013 | US20130004534 Inactivation of reverse transcriptases by azido-diarylpyrimidines |
| 01/03/2013 | US20130004532 Process for manufacturing vaccines |
| 01/03/2013 | US20130004531 Immunogens from uropathogenic escherichia coli |
| 01/03/2013 | US20130004529 Vaccines and methods for using the same |
| 01/03/2013 | US20130004528 Direct analysis of antigen-specific immune response |
| 01/03/2013 | US20130004527 Contiguous overlapping peptides for treatment of ragweed pollen allergy |
| 01/03/2013 | US20130004526 Utilization of Dialkylfumarates |
| 01/03/2013 | US20130004525 Inactivating pathogens with oxidizing agents for vaccine production |